1 / 28

None of the authors had disclosures with regard to the present study

Eight M onths A ngiographic F ollow-up in P atients R andomized to Crush or Culotte S tenting of C oronary A rtery B ifurcation L esions The Nordic Bifurcation Stent Technique Study.

phyre
Download Presentation

None of the authors had disclosures with regard to the present study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Eight Months Angiographic Follow-upin Patients Randomized to Crush or CulotteStenting of Coronary Artery Bifurcation LesionsThe Nordic Bifurcation Stent Technique Study PålGunnes, MattiNiemela, Kari Kervinen, AndrejsErglis, IndulisKumsars, Jens F Lassen, Michael Mæng, Jan Skov Jensen, Anders Galløe, TerjeSteigen, Jan Ravkilde, TimoMakikallio, Kari Ylitalo, Inga Narbute, Evald Christiansen, Lars Krusell, SindreStavnes, UlrikAbildgaard, Peter Riis Hansen, Jan Mannsverk, Thor Trovik, Per Thayssen, Steffen Helqvist, SailaVikman, Rune Wiseth, Jens Aarøe, Leif Thuesen For the Nordic-Baltic PCI Study Group

  2. None of the authors had disclosures with regard to the present study

  3. Nordic-Baltic PCI Study Group: independent working group of interventional cardiologists in the Nordic and Baltic countries The Cypher Select stents used in this study were purchased at market price An unrestricted grant of €625 was donated by Cordis JJ to the participating hospitals per randomized patient The Nordic Bifurcation Stent Technique Study

  4. Denmark Aarhus University Hospital, Skejby (83 pts) Gentofte University Hospital (44 pts) Odense University Hospital (14 pts) Rigshospitalet, Copenhagen (11 pts) Aalborg University Hospital (3 pts) Latvia Paul Stradins Hospital, Riga (92 pts) Finland Oulu University Hospital (87 pts) Helsinki University Hospital (11 pts) Tampere University Hospital (8 pts) Kuopio University Hospital (2 pts) Norway Feiring Heart Clinic (50 pts) Tromsø University Hospital (15 pts) St Olav Hospital, Trondheim (4 pts) Participating Centres

  5. Purpose In a randomized trial to compare • CRUSH • CULOTTE bifurcation stenting techniques using sirolimus-eluting stents

  6. Crush-stenting

  7. Crush-stenting Culotte-stenting

  8. Inclusioncriteria • Stable or unstable AP or silent ischemia • Bifurcation lesion of LAD/diagonal, Cx/obtuse marginal, RCA-PDA/posterolateral branch or LM/Cx/LAD in a right dominant system • Diameter of main vessel by visual estimate >3.0 mm • Diameter of side branch by visual estimate >2.5 mm

  9. Randomization (n: 424) CULOTTE (n: 215) CRUSH (n: 209) n: 424 (100%) Clinical Follow up, 6 months (n: 215) Clinical Follow up, 6 months (n: 209) n: 424 (100%) Stratification at randomization Scheduled Angiographic Follow up, 8 months (n:189) Scheduled Angiographic Follow up, 8 months (n: 184) n: 373 (88%) Angiographic FU available (n: 160) Angiographic FU available (n: 164) n: 324 (87%)

  10. Randomization (n: 424) CULOTTE (n: 215) CRUSH (n: 209) n: 424 (100%) Clinical Follow up, 6 months (n: 215) Clinical Follow up, 6 months (n: 209) n: 424 (100%) Stratification at randomization Scheduled Angiographic Follow up, 8 months (n:189) Scheduled Angiographic Follow up, 8 months (n: 184) n: 373 (88%) Angiographic FU available (n: 160) Angiographic FU available (n: 164) n: 324 (87%)

  11. Angiographic end points • In-lesion >50% stenosis of the entire bifurcation • In-stent >50% stenosis of the entire bifurcation • In lesion >50% stenosis of MV • In lesion >50% stenosis of SB • Late loss of MV and SB

  12. Baseline demographics CRUSHCULOTTE p-value (n=160) (n=164) Age (yrs) 65 64 ns Male sex (%) 76 75 ns Diabetes (%) 14 15 ns Smoker (%) 23 31 ns Hypertension (%) 63 64 ns Statin tx (%) 84 73 0.02 Family history (%) 54 62 ns History of PCI (%) 46 35 0.05 History of CABG (%) 3 6 ns

  13. Vessels treated CRUSH (n=160) CULOTTE (n=164) 10% 11% 5% 8% 16% 19% 62% 68% ns

  14. Procedural data CRUSH CULOTTE p-value (n=160) (n=164) MV stented (%) 100.0 99.4 ns SB stented (%) 99.4 97.0 ns Kissing balloon (%) 88.8 93.9 ns Tx successful* (%) 98.8 100.0 ns * (Residual stenosis <30% of MV + TIMI flow III in SB)

  15. Ejection fraction – Diseased Vessels

  16. Patients with true bifurcation lesion Medina classification 1,1,1 - 1,0,1 - 0,1,1 CRUSH CULOTTE p-value (n=160) (n=164) True bifurcation 125 (78%) 140 (85%) ns

  17. Quantitative coronary angiography (QCA) Computer-based system dedicated to bifurcation analysis (Qangio XA version 7.0, Medis, Leiden, The Netherlands) Angiographic core labs: • Aarhus University Hospital, Skejby, Denmark • Paul Stradins Clinical Hospital, Riga, Latvia

  18. Angiographic follow-up after 8 months Complete angiographic evaluation in 324 (87%) patients MV prox SB • QCA measurements in: • Proximal main vessel • Distal main vessel • Side branch • Edge (5 mm) MV dist

  19. Reference diameter (mm)before procedure mm ns ns ns

  20. Rate of mainvesseland/or side branch in-lesion diameter stenosis >50% at 8 monthsfollow-up % 12.1 p=0.10 6.6

  21. Rate of main vessel and/or side branch in-stent diameter stenosis >50% at 8 months follow-up % 10.5 p=0.046 4.5

  22. Rate of mainvessel in-lesion diameter stenosis >50% at 8 monthsfollow-up % p=0.19 4.7 2.0

  23. Rate of side branch in-lesion diameter stenosis >50% at 8 months follow-up % p=0.10 9.2 4.5

  24. Localization of in-stent restenosisat 8 months follow-up CRUSH CULOTTE 0.0% 0.0% 3.8%* 9.8%* 0.6% 2.0% * p=0.04

  25. Localization of edge restenosisat 8 months follow-up CHRUSH CULOTTE 0.0% 2.0% 2.0% 1.3% 1.3% 0.7%

  26. In-stent late lumen loss (mm) mm ns ns ns

  27. Conclusion • CRUSH and CULOTTE bifurcation stenting using sirolimus eluting stents were associated with low rates of restenosis at eight months angiographic follow-up • The few restenoses were primarily located in side branches treated with the CRUSH technique • The CULOTTE bifurcation stenting technique was associated with a single digit restenosis rate and may be preferred in suitable bifurcation anatomies • Extended follow-up needed to evaluate the safety of the investigated two-stent bifurcation techniques

More Related